advancing innovation to save lives

Celebrating ten years of GHTC & a decade of progress in global health innovation

As we close out our tenth anniversary year, we are reflecting on our shared progress and celebrating the headlines and moments that shaped global health R&D over the past decade.
Learn More

The first step

GHTC released a new two-minute video taking viewers on a journey to discover how sustained investments in global health R&D can unlock health and opportunity for people around the world.
View

Member spotlight: Sabin Vaccine Institute

The Sabin Vaccine Institute makes vaccines more accessible, enables innovation and expands immunization across the globe. As a non-profit with more than two decades of experience, Sabin embodies the legacy of its namesake, Dr. Albert B. Sabin, inventor of the oral polio vaccine and lifelong crusader against poverty and preventable disease. Sabin is committed to extending the full benefits of immunization to all people, regardless of who they are or where they live. Sabin has recently welcomed a major grant to spur innovation toward a universal influenza vaccine.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more
PATH/Matthew Dakin
GHTC policy officer pens Hill op-ed on links between global health and national security

GHTC policy officer, Courtney Carson, and Danielle Heiberg of GHC co-authored an opinion piece in The Hill, discussing the links between global health and national security and urging Congress not to make artificial distinctions between defense and non-defense discretionary spending—both of which are critical for protecting health around the world, and the health of Americans at home.

View
PATH/Will Boase
Fogarty Center's Global Health Matters covers two GHTC fact sheet series

The Fogarty International Center's newsletter, Global Health Matters, covered both GHTC's agency fact sheet series, examining the contributions of US government agencies to advancing global health R&D; and GHTC's introductory fact sheet series, examining the importance of global health R&D.
 

View
View All News & Events

Member Event

PATH/Patrick McKern
Global Classroom: What Does it Take to Eradicate Disease?
World Affairs Council/Bill & Melinda Gates Foundation Discovery Center
Learn More

Community Event

PATH/Gabe Bienczycki
Addressing Challenges in Global Health Security 2018
Geneva Centre for Security Policy
Learn More
View All Events
PATH/Georgina Goodwin
Research Roundup: Stem cells and TB, the research agenda to end malaria, and a monkey species role in ending AIDS

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Aaron Joel Santos
Five issues to watch in US global health R&D policy in 2018

2018 is shaping up to be another important year for US policy related to global health and medical research. As Congress returns for a busy work session and the White House continues to roll out policy reforms, here are the top five issues GHTC will be following in 2018.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide